Joint Formulary & PAD

Molnupiravir - Covid-19

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Not Specified
Associated Icons :
Restrictions / Comments :
Important

Primary care and outpatient prescribing of antivirals for COVID 19 treatment is through the CMDU service

 

Status 2

Red
Formulations :
  • Not Specified
Associated Icons :
Restrictions / Comments :
Important

Primary care and outpatient prescribing of antivirals for COVID 19 treatment is through the CMDU service

Documents :
 

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Molnupiravir
Indication :
Covid-19
Group Name :
Keywords :
Covid 19, Coronavirus, antivirals
Brand Names Include :
Lagevrio
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Molnupiravir is used to treat.

  • No records returned.

Committee Recommendations (1)

DO NOT prescribe in primary care.

This drug is recommended in the treatment of COVID-19 ONLY in line with NHSE commissioning policies which include detail on eligibility and exclusion criteria for:

  • Non-hospitalised patients - Refer eligible patients from Surrey Heartlands and Frimley to the East Berkshire Primary Care Covid Medicine Delivery Unit.
  • Hospitalised patients – Hospital treatment of those with acute Covid-19 illness OR with hospital onset Covid-19